1. A therapeutic agent for the treatment of lower urinary tract disease, wherein the agent comprises a thrombin-like enzyme. ! 2. A therapeutic agent for treating a lower urinary tract disease according to claim 1, wherein the thrombin-like enzyme is selected from the group consisting of batroxobin, ankrod, and crotalase. ! 3. A therapeutic agent for treating a lower urinary tract disease according to claim 1, wherein the thrombin-like enzyme is batroxobin. ! 4. A therapeutic agent for the treatment of lower urinary tract disease according to any one of paragraphs. 1-3, where the lower urinary tract disease is selected from the group consisting of cystitis, prostatitis and benign prostatic hyperplasia. ! 5. The therapeutic agent for the treatment of lower urinary tract disease according to any one of paragraphs. 1-3, where the lower urinary tract disease is selected from the group consisting of hemorrhagic cystitis, interstitial cystitis, chronic non-bacterial prostatitis and benign prostatic hyperplasia. ! 6. An agent for improving a lower urinary tract symptom associated with a lower urinary tract disease, wherein the agent comprises a thrombin-like enzyme. ! 7. A means for improving a lower urinary tract symptom associated with a lower urinary tract disease according to claim 6, wherein the thrombin-like enzyme is selected from the group consisting of batroxobin, ancrod and crotalase. ! 8. An agent for improving a lower urinary tract symptom associated with a lower urinary tract disease according to claim 6, wherein the thrombin-like enzyme is batroxobin. ! 9. Means for improving the lower urinary tract symptom associated with lower urine disease1. Терапевтическое средство для лечения заболевания нижних мочевых путей, где средство включает тромбиноподобный фермент. ! 2. Терапевтическое средство для лечения заболевания нижних мочевых путей по п. 1, где тромбиноподобный фермент выбран из группы, состоящей из батроксобина, анкрода и кроталазы. ! 3. Терапевтическое
